[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336794-105":59,"doc-detail-336794-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","clinicopathological-and-prognostic-significance-of-stromal-cell-derived-factor-2-in-the-patients-with-gastric-cancer","Clinicopathological and prognostic significance of stromal cell derived factor 2 in the patients with gastric cancer","","Background: Stromal cell derived factor 2 (SDF2) is linked to cancer occurrence and progression, but its clinicopathological and prognostic value in gastric cancer remains insufficient. Methods: SDF2 expression was evaluated in gastric cancer and normal gastric tissues using bioinformatics, western blot, and immunohistochemistry, and its associations with clinicopathological features and patient prognosis were analyzed. Results: SDF2 expression was higher in tumor tissues and correlated with advanced Borrmann classification, deeper infiltration, lymph node metastasis, and TNM stage; Cox regression identified distant metastasis, TNM stage, and high SDF2 as independent risk factors for OS, and Kaplan-Meier showed worse overall survival with high SDF2.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/clinicopathological-and-prognostic-significance-of-stromal-cell-derived-factor-2-in-the-patients-with-gastric-cancer/336794/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/clinicopathological-and-prognostic-significance-of-stromal-cell-derived-factor-2-in-the-patients-with-gastric-cancer/336794.png","ImageObject",300,407,{"name":92,"@type":93},"Riley","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"How was SDF2 expression measured in gastric cancer tissues?","Question",{"text":113,"@type":114},"SDF2 expression in gastric cancer and normal gastric tissues was assessed using bioinformatics analysis, western blot, and immunohistochemistry.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which clinicopathological features were associated with high SDF2 expression?",{"text":118,"@type":114},"High SDF2 expression correlated with Borrmann classification III-IV, tumor infiltration depth (T3-T4), positive lymph node metastasis, and TNM stage III-IV.",{"name":120,"@type":111,"acceptedAnswer":121},"Does high SDF2 expression predict overall survival in gastric cancer patients?",{"text":122,"@type":114},"Yes. Cox regression showed that high SDF2 expression is an independent risk factor for overall survival, and Kaplan-Meier analysis indicated significantly poorer OS in the SDF2 high-expression group.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},336794,1790190452,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":39,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":46,"preview_page_count":19,"preview_urls":145},1374391975076,"https://ap-avatar.wpscdn.com/avatar/14000253ca4ec9f6853?x-image-process=image/resize,m_fixed,w_180,h_180&k=1783305029341752051","Wang et al. BMCGastroenterology (2024) 24:325 [https://doi.org/10.1186/s12876-024-03430-5](https://doi.org/10.1186/s12876-024-03430-5)  \nBMC Gastroenterology  \nRESEARCH Open Access  \nClinicopathological and prognostic significance of stromal cell derived factor 2 in the patients with gastric cancer  \nYuhang Wang 1,2†, Mingcan Zheng 1,2†, Shaohua Du 1,2†, Puxu Wang 1,2, Taotao Zhang 1, Xiangwen Zhang 1 and Guo Zu 1*  \nAbstract  \nBackground The stromal cell derived factor 2 (SDF2) relates closely to the occurrence and development of several kind of cancers. There are few studies to investigate the clinicopathological and prognostic significance of SDF2 in gastric cancer (GC) patients.  \nMethods We detected SDF2 expression in GC and normal gastric tissues using bioinformatics, western blot and immunohistochemistry. Furthermore, we tested the relationship between SDF2 expression and clinicopathological characteristics and prognosis of GC patients.  \nResults Bioinformatics, western blot and immunohistochemistry results showed that SDF2 expression in GC tissue was higher than that in normal gastric tissue (P \u003C 0. 01) . SDF2 expression was associated with Borrmann classification III-IV (χ2 = 6 .484, P = 0 . 011), depth of infiltration T3-T4 (χ2 = 9 . 140, P = 0 . 003), positive lymph node metastasis (χ2 = 24 . 945, P = 0 . 000) and TNM III-IV stage (χ2 = 9 . 945, P = 0 . 002) of GC patients. The Cox regression analysis indicated that distant metastasis M1 stage (HR = 6 . 026, 95% CI: 1.880-19. 318, P = 0 . 003), TNM III-IV (HR = 1 . 833, 95% CI: 1.023–3. 287, P = 0 . 042) and SDF2 high expression (HR = 2 . 091, 95% CI: 1.064–4. 108, P = 0 . 032) were independent risk factors for OS of GC patients. Kaplan-Meier test showed that the OS of GC patients with SDF2 high expression was much poorer than that of GC patients with SDF2 low-expression (χ2 = 22 . 925, P = 0 . 000) .  \nConclusion SDF2 expression is high in GC tissue and is correlated with Borrmann classification III-IV, tumor infiltration depth, positive lymph node metastasis and TNM III-IV stage of GC patients. GC patients with SDF2 high-expression have significantly poor OS.  \nKeywords SDF2, Gastric cancer, Clinicopathological significance, Prognosis, Bioinformatics  \n†Yuhang Wang, Mingcan Zheng and Shaohua Du are co-first authors.  \n*Correspondence:  \nGuo Zu  \n[zuguodl@dl ut.edu.cn](zuguodl@dl ut.edu.cn)  \n1Department of Gastroenterology Surgery, The Central Hospital of Dalian University of Technology (Dalian Municipal Central Hospital), Dalian Shahekou District Southwest Road No. 826, Dalian 116033, PR China 2Department of Graduate School, Dalian Medical University,  \nDalian 116044, China  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://](http://)[ ](http://)[creativecommons.org/l](creativecommons.org/l)icenses/by-nc-nd/4.0/.  \nWang et al. BMC Gastroenterology (2024) 24:325  \nBackground  \nGastric cancer (GC) is the fifth most common cancersin the world with high prevalence and poor survival and a global health challenge [1, 2]. In recent yea","cbCaih0zZKXfoc7m","https://ap.wps.com/l/cbCaih0zZKXfoc7m","pdf",3853415,"English","# Background\n# Methods\n# Results\n# Conclusion\n# Keywords","[{\"question\":\"How was SDF2 expression measured in gastric cancer tissues?\",\"answer\":\"SDF2 expression in gastric cancer and normal gastric tissues was assessed using bioinformatics analysis, western blot, and immunohistochemistry.\"},{\"question\":\"Which clinicopathological features were associated with high SDF2 expression?\",\"answer\":\"High SDF2 expression correlated with Borrmann classification III-IV, tumor infiltration depth (T3-T4), positive lymph node metastasis, and TNM stage III-IV.\"},{\"question\":\"Does high SDF2 expression predict overall survival in gastric cancer patients?\",\"answer\":\"Yes. Cox regression showed that high SDF2 expression is an independent risk factor for overall survival, and Kaplan-Meier analysis indicated significantly poorer OS in the SDF2 high-expression group.\"}]","Clinicopathological and prognostic significance of stromal cell derived factor 2 in the patients with gastric cancer | PDF",1790016637,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/011657fe4c782b54e3992aab3d8daf66.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/872d1edd245a86eaacc01149132d1e51.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4383e9e26e069f672942364b37c1ef63.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3ef8101216effb11c69104a4a4ed79b8.webp",980,1306]